Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Neuroma, Acoustic

• Nimodipine in Vestibular Schwanommas
• Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF
• Innovative Trial for Understanding the Impact of Targeted Therapies in NF2
• Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560
• Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
• Compare the Operating Condition of Two Levels of Muscle Relaxation on Facial Nerve MEP Monitoring in CPA Surgery
• AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery
• RGD PET/MRI in Sporadic Vestibular Schwannoma
• Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
• Study of Aspirin in Patients With Vestibular Schwannoma
• Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma
• Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
• Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function
• Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function
• Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
• Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
• Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
• Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
• Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
• Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients
• Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
• A Study of Nilotinib in Growing Vestibular Schwannomas
• RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
• Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
• Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
• Concentration and Activity of Lapatinib in Vestibular Schwannomas